THRX — Theseus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $181.72m
- -$23.40m
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7
U.S. STOCKS ON THE MOVE-DR Horton, Federal Realty, RedHill Biopharma
U.S. STOCKS ON THE MOVE-Affirm, Lucid, Domino's Pizza
U.S. STOCKS ON THE MOVE-Theseus Pharma, Shopify, Mondelez International
Theseus Pharma rises after joint buyout offer from top stakeholders
Brief: Theseus Pharmaceuticals Confirms Receipt Of Unsolicited Expression Of Interest From Foresite Capital, Orbimed Advisors And Unsolicited Proposal From Concentra Biosciences
Brief: Orbimed Advisors Llc Reports 40.1% Stake In Theseus Pharmaceuticals Inc
Theseus Pharma rises on buyout offer from Concentra
Theseus Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
U.S. STOCKS ON THE MOVE-Gold miners, Big Tech, Talis Biomedical
U.S. STOCKS ON THE MOVE-US banks, Splunk, ReAlpha Tech
U.S. STOCKS ON THE MOVE-Snap, Tesla, BioCardia
Theseus Pharma up after plans to explore strategic alternatives, job cuts
Theseus Pharma gains on plans to explore strategic alternatives, job cuts
Brief: Theseus Pharmaceuticals Says Terminated Employment Of William Shakespeare As President Of Research And Development As Part Of Workforce Reduction
Theseus Pharmaceuticals Inc expected to post a loss of 36 cents a share - Earnings Preview